The Relationship Between Receipt of Opioid Settlement Funds and Reductions in Opioid Overdose Deaths in the U.S.
AJPM Focus · 2025-12 · 4 (6) · 100424
DOI: 10.1016/j.focus.2025.100424 ↗Kurz gefasst
Fachartikel in der Zeitschrift AJPM Focus, 2025-12. Verfasst von Ryan K McBain und 4 weiteren Autor:innen. Beteiligte Einrichtung: RAND, Arlington, Virginia. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 12 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NIDA NIH HHS, Henry J. Kaiser Family Foundation, National Institute on Drug Abuse.
Abstract (Originalsprache)
Introduction
The ongoing distribution of funds from the national settlement agreements with opioid distributors and manufacturers presents a unique opportunity to mitigate the morbidity and mortality associated with opioid use. In this study, the authors examine whether larger per-capita settlement disbursements correspond to greater reductions in opioid-related overdose deaths since then and the extent to which states with higher baseline opioid-related overdose death rates receive greater per-capita settlement disbursements.
Methods
Using national data on opioid settlement disbursements from the Kaiser Family Foundation and overdose deaths from the Centers for Disease Control and Prevention, the authors estimated an event study using a Poisson regression to compare trends in overdose deaths during the predisbursement period (2017-2021) with those observed in the postdisbursement period (2022-2023). The authors then quantified the magnitude of settlement disbursements in 2022-2023 relative to opioid-related overdose death rates in the 5 preceding years.
Results
Each additional per-capita dollar of settlement funds was associated with a 0.99% larger decline in opioid-related overdose deaths in 2022 (95% CI= -1.90%, -0.08%; p=0.03) and a 2.46% decline in 2023 (95% CI= -4.17%, -0.75%; p=0.01). The authors also found a significant association between opioid-related overdose death rates in the 5 years prior to disbursements and the magnitude of per-capita disbursements (2022-2023). Each additional opioid-related overdose death per 100,000 residents was associated with a $0.87 greater per-capita disbursement (95% CI=$0.43, $1.31; p
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- RAND, Arlington, Virginia.
- Brigham & Women's Hospital, Boston, Massachusetts.
- RAND, Santa Monica, California.
- Edward J. Bloustein School of Planning and Public Policy, Rutgers University, New Brunswick, New Jersey.
- University of Pennsylvania, Philadelphia, Pennsylvania.
Förderung
- NIDA NIH HHS
- Henry J. Kaiser Family Foundation
- National Institute on Drug Abuse
Zitieren
APA
McBain, R. K., Cantor, J. H., Kofner, A., Lindenfeld, Z., & Powell, D. (2025). The Relationship Between Receipt of Opioid Settlement Funds and Reductions in Opioid Overdose Deaths in the U.S. AJPM Focus, 4(6), 100424. https://doi.org/10.1016/j.focus.2025.100424
Vancouver
McBain RK, Cantor JH, Kofner A, Lindenfeld Z, Powell D. The Relationship Between Receipt of Opioid Settlement Funds and Reductions in Opioid Overdose Deaths in the U.S. AJPM Focus. 2025;4(6):100424. doi:10.1016/j.focus.2025.100424
BibTeX
@article{McBain2025,
author = {McBain, Ryan K and Cantor, Jonathan H and Kofner, Aaron and Lindenfeld, Zoe and Powell, David},
title = {The Relationship Between Receipt of Opioid Settlement Funds and Reductions in Opioid Overdose Deaths in the U.S},
journal = {AJPM Focus},
year = {2025},
volume = {4},
number = {6},
pages = {100424},
doi = {10.1016/j.focus.2025.100424}
}
EUVIMED